STOCK TITAN

SOHM, Inc. Signs Industry Expert Sivana Group as Strategic Consultant for Rebranding and Global Expansion

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Very Positive)
Tags
Rhea-AI Summary

SOHM, Inc. (OTC PINK:SHMN) announced a strategic engagement with Sivana Group to enhance its rebranding and global expansion efforts. This collaboration aims to harness Sivana's industry expertise to develop product portfolios and a long-term growth strategy. Mr. Baron Night, CEO of SOHM, emphasized Sivana's capabilities in brand strategy and business relationships. The partnership aligns with SOHM's vision of 'Globalé Prospéro' and seeks to broaden its reach in the pharmaceutical, nutraceutical, and cosmeceutical sectors globally.

Positive
  • Strategic partnership with Sivana Group for rebranding and expansion.
  • Utilization of Sivana's industry expertise to enhance product portfolio.
  • Alignment with the 'Globalé Prospéro' vision for growth.
Negative
  • None.

SOHM, Inc. takes a step forward in achieving maximum value for their organizations' stakeholders with strategic rebranding and global expansion

CHINO HILLS, CA / ACCESSWIRE / November 15, 2021 / SOHM, Inc. (OTC PINK:SHMN), a generic Pharmaceutical, Nutraceutical, and Cosmeceutical company that manufactures and markets generic drugs covering numerous treatment categories announced today that it has signed an engagement agreement with Southern California based Sivana Group, Inc.

Mr. Baron Night, President and CEO of SOHM Inc., said, "Sivana Group brings exceptional industry experience, strong business relationships, successful branding strategies, and boundless creativity to our company and its extensive product line. Sivana Group will initially be tasked with developing a rebranding and expansion plan, developing product portfolios, and determining a long-term growth strategy."

Sivana Group is a Southern California-based corporation that helps its clients address their toughest challenges and navigate regulatory pressures with a focus on transformational change, business resiliency, and technology-driven innovation. This agreement further advances the company towards achieving its "Globalè Prospèro" vision.

Shelley Mehta, Founder and CEO of Sivana Group, stated, "Our experience is in execution and commercialization strategies for companies who operate in the 'eutical' industry, including the pharmaceutical and cosmeceutical industry where SOHM operates". Mehta continued, "We work with large corporate enterprises wanting to further commercialize their existing technologies and intellectual property into new markets and segments. The collaboration of our two companies creates a powerful opportunity for expanding SOHM's product line into an even greater audience in the pharmaceutical, cosmeceutical, and nutraceutical industries."

About SOHM, Inc.
SOHM, Inc., is a growing generic pharmaceutical manufacturing and marketing company with a vision "Globalè Prospèro" that tries to build continuous growth. SOHM manufacturing and marketing targets the rapidly growing healthcare segments such as Nutraceuticals, Cosmeceuticals, and other major therapeutic segments. SOHM is headquartered in North America with manufacturing alliances in India as well as has strategic alliances with US manufacturing facilities. Although SOHM's generic pharmaceuticals are exported globally and were introduced to the USA in early 2013, SOHM continues its focus on distribution to emerging markets in Africa, Latin America, and Southeast Asia.
To learn more about SOHM, Inc., visit www.SOHM.com

Safe Harbor Statement:
This news release contains "forward-looking statements", which are statements that are not purely historical and include any statements regarding beliefs, plans, expectations, or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs, and results of new business opportunities. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects and development stage companies. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations, and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations, or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report for the most recent fiscal year, our quarterly reports uploaded from time-to-time on OTCMarkets.com.

For more information, please contact:
SOHM, Inc.
714-522-6700

SOURCE: SOHM, Inc.



View source version on accesswire.com:
https://www.accesswire.com/672811/SOHM-Inc-Signs-Industry-Expert-Sivana-Group-as-Strategic-Consultant-for-Rebranding-and-Global-Expansion

FAQ

What is the recent partnership announced by SOHM, Inc. (SHMN)?

SOHM, Inc. announced a partnership with Sivana Group to assist in rebranding and global expansion.

What are the goals of SOHM's engagement with Sivana Group?

The goals include developing a rebranding strategy, expanding product portfolios, and creating a long-term growth plan.

How does SOHM, Inc. plan to achieve its 'Globalé Prospéro' vision?

SOHM aims to achieve its vision through strategic partnerships like the one with Sivana Group, which focuses on expanding its product line.

What industries does SOHM, Inc. operate in?

SOHM operates in the pharmaceutical, nutraceutical, and cosmeceutical industries.

When was the partnership with Sivana Group announced?

The partnership was announced on November 15, 2021.

SOHM INC

OTC:SHMN

SHMN Rankings

SHMN Latest News

SHMN Stock Data

1.99M
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States of America
Corona